In Silico Trials of an Open-Source Android-Based Artificial Pancreas: A New Paradigm to Test Safety and Efficacy of Do-It-Yourself Systems-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Silico Trials of an Open-Source Android-Based Artificial Pancreas: A New Paradigm to Test Safety and Efficacy of Do-It-Yourself Systems

Published:2020-02-01 Issue:2 Volume:22 Page:112-120
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Toffanin Chiara¹,Kozak Milos²,Sumnik Zdenek³,Cobelli Claudio⁴,Petruzelkova Lenka³

Affiliation:

1. Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.

2. CLOSED LOOP Systems, Prague, Czech Republic, Prague, Czech Republic.

3. Department of Paediatrics, Motol University Hospital, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.

4. Department of Information Engineering, University of Padova, Padova, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2019.0375

Reference34 articles.

1. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials

2. Metrics for glycaemic control — from HbA1c to continuous glucose monitoring

3. Real-World Use of Open Source Artificial Pancreas Systems

4. Excellent Glycemic Control Maintained by Open-Source Hybrid Closed-Loop AndroidAPS During and After Sustained Physical Activity

5. Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS)

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management;Diabetes Technology & Therapeutics;2024-05-13

2. Breaking a feedback loop: A reassessment of an investigator initiated OS‐AID study;Diabetes, Obesity and Metabolism;2023-10-05

3. Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility;Journal of Diabetes Science and Technology;2023-09-25

4. Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial;BMJ Open;2023-08

5. A systematic review of cardiac in-silico clinical trials;Progress in Biomedical Engineering;2023-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3